Actively Recruiting
Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.
Led by China-Japan Friendship Hospital · Updated on 2025-11-19
200
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aimed to explore the effects of preoperative intravenous isomaltose iron supplementation versus placebo on postoperative Hb improvement, prevention of postoperative anemia, and improvement in quality of life in patients undergoing bariatric surgery.
CONDITIONS
Official Title
Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Baseline hemoglobin: Men 10-14 g/dL, Women 10-13 g/dL
- Iron deficiency with serum ferritin less than 100 µg/L and transferrin saturation less than 20%
- Body mass index (BMI) greater than 30 kg/m2
You will not qualify if you...
- Known severe hypersensitivity to parenteral iron supplements
- Mean corpuscular volume (MCV) greater than 100 fL
- Received intravenous iron infusion within the past 3 months
- Presence of tumors
- Iron overload or other blood disorders
- Infectious diseases such as hepatitis B
- Moderately impaired liver function including decompensated cirrhosis or hepatitis with ALT, AST over 3 times upper normal limit
- Acute or chronic infections, heart failure, or diseases affecting iron metabolism
- Chronic kidney disease stage 3 or higher with glomerular filtration rate less than 60 ml/min
- Pregnant or breastfeeding women
- Acute infections, rheumatoid arthritis, or significant joint inflammation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
China-Japan Friendship Hospital
Beijing, China
Actively Recruiting
Research Team
N
Nianrong Zhang Zhang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here